324 related articles for article (PubMed ID: 25400636)
1. Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV.
Laidlaw SM; Dustin LB
Front Immunol; 2014; 5():545. PubMed ID: 25400636
[TBL] [Abstract][Full Text] [Related]
2. Type III Interferons in Hepatitis C Virus Infection.
Boisvert M; Shoukry NH
Front Immunol; 2016; 7():628. PubMed ID: 28066437
[TBL] [Abstract][Full Text] [Related]
3. Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses.
Grzegorzewska AE
Curr Med Chem; 2019; 26(25):4832-4851. PubMed ID: 30027841
[TBL] [Abstract][Full Text] [Related]
4. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
Israelow B; Narbus CM; Sourisseau M; Evans MJ
Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity and HCV.
Heim MH
J Hepatol; 2013 Mar; 58(3):564-74. PubMed ID: 23063572
[TBL] [Abstract][Full Text] [Related]
6. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
[TBL] [Abstract][Full Text] [Related]
7. Role of Interferons in Chronic Hepatitis C Infection.
Scagnolari C; Monteleone K; Cacciotti G; Antonelli G
Curr Drug Targets; 2017; 18(7):844-850. PubMed ID: 26844564
[TBL] [Abstract][Full Text] [Related]
8. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
9. The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.
Bruening J; Weigel B; Gerold G
J Immunol Res; 2017; 2017():7232361. PubMed ID: 28255563
[TBL] [Abstract][Full Text] [Related]
10. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
11. Association between IFN-λ 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian Patients.
El-Garawani I; Hassab El-Nabi S; Gadallah M; Abdelsameea E
Immunol Invest; 2021 Jan; 50(1):12-22. PubMed ID: 32024403
[No Abstract] [Full Text] [Related]
12. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
13. Herpesviruses and the Type III Interferon System.
Yin Y; Favoreel HW
Virol Sin; 2021 Aug; 36(4):577-587. PubMed ID: 33400088
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the anti-HCV mechanisms of interferon.
Huang M; Jiang JD; Peng Z
Acta Pharm Sin B; 2014 Aug; 4(4):241-7. PubMed ID: 26579391
[TBL] [Abstract][Full Text] [Related]
15. Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals.
Sung PS; Shin EC
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276399
[TBL] [Abstract][Full Text] [Related]
16. Innate and adaptive immune responses in HCV infections.
Heim MH; Thimme R
J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
[TBL] [Abstract][Full Text] [Related]
17. Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells.
Doldan P; Dai J; Metz-Zumaran C; Patton JT; Stanifer ML; Boulant S
J Virol; 2022 Sep; 96(17):e0070622. PubMed ID: 36000839
[TBL] [Abstract][Full Text] [Related]
18. Innate Immunity in Hepatitis C Virus Infection.
Schwerk J; Negash A; Savan R; Gale M
Cold Spring Harb Perspect Med; 2021 Feb; 11(2):. PubMed ID: 32341066
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response.
Read SA; Tay ES; Shahidi M; O'Connor KS; Booth DR; George J; Douglas MW
PLoS One; 2015; 10(8):e0136227. PubMed ID: 26313459
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
Wang Y; Ye L; Wang X; Li J; Song L; Ho W
Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
